Item Number: MILBACTD
Milbactor Tablets for dogs weighing at least 5 kg.
In dogs: treatment of mixed infections by adult cestodes and nematodes of the following species:
Cestodes:
Dipylidium caninum
Taenia spp.
Echinococcus spp.
Mesocestoides spp.
Nematodes:
Ancylostoma caninum
Toxocara canis
Toxascaris leonina
Trichuris vulpis
Crenosoma vulpis (Reduction of the level of infection)
Angiostrongylus vasorum (Reduction of the level of infection by immature adult (L5) and adult parasite stages; see specific treatment and disease prevention schedules under 'Dosage and administration').
Thelazia callipaeda (see specific treatment schedule under 'Dosage and administration').
The product can also be used in the prevention of heartworm disease (Dirofilaria immitis), if concomitant treatment against cestodes is indicated.
Dosage and administration
Oral use.
Dogs should be weighed to ensure accurate dosing.
Minimum recommended dose rate: 0.5 mg of milbemycin oxime and 5 mg of praziquantel per kg are given once orally.
The product should be administered with or after some food.
Depending on the bodyweight of the dog, the practical dosing is as follows:
Bodyweight (kg)
No. small dogs and puppies tablets
No. dogs weighing at least 5 kg tablets
Bodyweight (kg) |
No. small dogs & puppies tablets |
No. dogs weighing at least 5 kg tablets |
0.5 - 1 |
½ |
|
> 1 - 5 |
1 |
|
> 5 - 10 |
2 |
|
> 5 - 25 |
1 | |
> 25 - 50 |
2 | |
> 50 - 75 |
3 |
In cases when heartworm disease prevention is used and at the same time treatment against tapeworm is required, the product can replace the monovalent product for the prevention of heartworm disease.
For treatment of Angiostrongylus vasorum infections, milbemycin oxime should be given four times at weekly intervals. It is recommended, where concomitant treatment against cestodes is indicated, to treat once with the product and continue with the monovalent product containing milbemycin oxime alone, for the remaining three weekly treatments.
In endemic areas administration of the product every four weeks will prevent angiostrongylosis by reducing immature adult (L5) and adult parasite burden, where concomitant treatment against cestodes is indicated.
For the treatment of Thelazia callipaeda, milbemycin oxime should be given in 2 treatments, seven days apart. Where concomitant treatment against cestodes is indicated, the product can replace the monovalent product containing milbemycin oxime alone.
Packaging Quantities
Box with 1 blister of 4 tablets.
Box with 12 blisters, each blister contains 4 tablets.
Not all pack sizes may be marketed.
MILBACTD PK4: Data Sheet
MILBACTD PK48: Data Sheet